Table 3 Association between KDM2A mRNA expression and clinical features in ccRCC
Parameters | n | KDM2A mRNA expression in ccRCC | P | |
|---|---|---|---|---|
Low, n (%) | High, n (%) | |||
Gender | ||||
Male | 29 | 12 (41.4%) | 17 (58.6%) | 0.152 |
Female | 21 | 13 (61.9%) | 8 (38.1%) | |
Age, years | ||||
< 60 | 28 | 13 (46.4%) | 15 (53.6%) | 0.569 |
≥ 60 | 22 | 12 (54.5%) | 10(45.5%) | |
Location | ||||
Left | 22 | 12 (54.5%) | 10 (45.5%) | 0.569 |
Right | 28 | 13 (46.4%) | 15 (53.6%) | |
BMI (kg/m2) | ||||
< 24 | 20 | 7 (35.0%) | 13 (65.0%) | 0.083 |
≥ 24 | 30 | 18(60.0%) | 12 (40.0%) | |
Tumor size (cm) | ||||
≤ 7 | 35 | 22 (62.9%) | 13(37.1%) | 0.005 |
> 7 | 15 | 3 (20.0%) | 12 (80.0%) | |
Smoking | ||||
No | 39 | 20 (51.3%) | 19 (48.7%) | 0.733 |
Yes | 11 | 5 (45.5%) | 6 (54.5%) | |
Thrombus of renal vein | ||||
No | 46 | 24 (52.2%) | 22 (47.8%) | 0.602 |
Yes | 4 | 1 (25.0%) | 3 (75.0%) | |
TNM stage | ||||
T1–T2 | 38 | 22 (57.9%) | 16 (42.1%) | 0.047 |
T3–T4 | 12 | 3 (25.0%) | 9 (75.0%) | |
ISUP grade | ||||
1–2 | 35 | 19(54.3%) | 16 (45.7%) | 0.355 |
3–4 | 15 | 6 (40.0%) | 9 (60.0%) | |
Symptoms | ||||
No | 32 | 15 (46.9%) | 17 (53.1%) | 0.556 |
Yes | 18 | 10 (55.6%) | 8 (44.4%) | |
Hypertension | ||||
No | 29 | 16 (55.2%) | 13 (44.8%) | 0.390 |
Yes | 21 | 9 (42.9%) | 12 (57.1%) | |